Meeta Chatterjee's most recent trade in Werewolf Therapeutics Inc was a trade of 27,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Werewolf Therapeutics Inc | Meeta Chatterjee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 27,000 | 27,000 | - | - | Stock Option (right to buy) | |
| Editas Medicine Inc | Meeta Chatterjee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Werewolf Therapeutics Inc | Meeta Chatterjee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2024 | 17,500 | 17,500 | - | - | Stock Option (right to buy) | |
| Werewolf Therapeutics Inc | Meeta Chatterjee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 13,200 | 13,200 | - | - | Stock Option (right to buy) | |
| Editas Medicine Inc | Meeta Chatterjee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Editas Medicine Inc | Meeta Chatterjee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Werewolf Therapeutics Inc | Meeta Chatterjee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 7,733 | 7,733 | - | - | Stock Option (right to buy) | |
| Werewolf Therapeutics Inc | Meeta Chatterjee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2021 | 23,200 | 23,200 | - | - | Stock Option (right to buy) | |
| Editas Medicine Inc | Meeta Chatterjee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2021 | 11,538 | 11,538 | - | - | Stock Option (right to buy) | |
| Editas Medicine Inc | Meeta Chatterjee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2020 | 23,076 | 23,076 | - | - | Stock Option (right to buy) |